Management of child and adolescent stuttering with olanzapine: three case reports.
Vast arrays of medications have been used, with limited success, to manage stuttering. Haloperidol and risperidone are the only two medications that have shown efficacy via double-blind studies in controlling stuttering symptoms. We present the first case reports of olanzapine in the management of stuttering. Three case histories are presented: a 10-year-old boy, a 16-year-old male adolescent with developmental stuttering, and a 9-year-old boy with medication-induced stuttering whose symptoms are successfully controlled with olanzapine. These case studies suggest that olanzapine may be a pharmacologic option in the management of stuttering.
Lavid
N
N
Department of Psychiatry and Human Behavior, University of California at Irvine Medical Center, Orange 92868, USA.
Franklin
D L
DL
Maguire
G A
GA
D000293:Adolescent; D001569:Benzodiazepines; D002648:Child; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013342:Stuttering / Q000188:drug therapy*
D001569:Benzodiazepines; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors